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ABSTRACT 
Background. Persistence of myofibroblasts is believed to contribute to the development of 
fibrosis in idiopathic pulmonary fibrosis (IPF). Transforming growth factor-ß1 (TGF-ß1) 
irreversibly converts fibroblasts into pathological myofibroblasts, which express smooth 
muscle -actin (-SMA) and produce extracellular matrix proteins, such as procollagen I 
(1). Reactive oxygen species (ROS) produced by NADPH oxidases (NOX) have been 
shown to regulate cell differentiation. We hypothesized that NOX could be expressed in 
parenchymal pulmonary fibroblasts and could mediate TGF-ß1–stimulated conversion of 
fibroblasts to myofibroblasts. 
Methods. Fibroblasts were cultured from the lung of 9 Control and 8 IPF patients. We 
quantified NOX4, -SMA and procollagen I (1) mRNA and protein expression, ROS 
production and Smad2/3 phosphorylation, in the absence and in the presence of incubation 
with TGF-ß1. PDGF-induced fibroblasts migration was also assessed. 
Results. We found that (1) NOX4 mRNA and protein expression was upregulated in 
pulmonary fibroblasts from patients with IPF and correlated with mRNA expression of -
SMA and procollagen I (1) mRNA; (2) TGF-ß1 upregulated NOX4, -SMA and 
procollagen I (1) expression in control and IPF fibroblasts; (3) the change in -SMA and 
procollagen I (1) expression in response to TGF-ß1 was inhibited by antioxidants and by a 
NOX4 siRNA; (4) NOX4 modulated -SMA and procollagen I (1) expression by controlling 
activation of Smad 2/3, and (5) NOX4 modulated PDGF-induced fibroblasts migration. 
Conclusion. NOX4 is critical for modulation of pulmonary myofibroblast phenotype in IPF, 
probably by modulating the response to TGF-ß1 and PDGF. 
Word count in abstract: 239 
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INTRODUCTION 
Idiopathic pulmonary fibrosis (IPF) is the most common idiopathic interstitial pneumonia. IPF 
is a disease with poor prognosis and an aggressive nature, and poses major challenges to 
clinicians (1) (2). Currently, no effective therapies exist to stop ongoing fibrosis in IPF. 
Accumulation and persistence of myofibroblasts is believed to contribute to the development 
of fibrosis (3). Alpha-smooth muscle actin (-SMA) expression, increased proliferative 
capacity, and increased generation and secretion of the extracellular matrix (ECM) proteins 
such as collagen and fibronectin are key hallmarks of myofibroblast differentiation in fibrotic 
disorders (4). It has been established that myofibroblast differentiation occurs through 
combinatorial signals involving TGF-1 and integrin signalling (5). 
Several studies suggest that oxidant–antioxidant imbalances in the lower respiratory tract play 
a significant role in the pathogenesis of IPF. Reactive oxygen species (ROS) can promote a 
profibrogenic environment in the lung through the modulation of the protease-antiprotease 
balance (6). Also, ROS activate and/or mediate the effects of growth-regulatory cytokines, 
including TGF-1 (7) (8). However, the endogenous sources of oxidants in IPF are poorly 
known. 
The NADPH oxidases (NOX) proteins generate ROS, namely superoxide, by electron transfer 
to oxygen. Superoxide can be further converted to hydrogen peroxide by cellular superoxide 
dismutases. NADPH oxidases consist of membrane-associated and cytosolic subunits (for 
review, see reference (9)). The most thoroughly investigated NADPH oxidase is the 
phagocytic gp91
phox
 (NOX2)-containing subunit that interacts with a second membrane bound 
subunit, p22
phox
, and several cytosolic and regulatory subunits including p47
phox
, p67
phox
, and 
Rac. Both NOX1 and NOX4 are homologs of NOX2, and are expressed in different 
nonphagocytic cells (9). It has been recently shown that NOX1 and NOX4 are expressed in 
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pulmonary arterial adventitial fibroblasts and that NOX4 contributes to the increase in ROS 
generation under hypoxic conditions, stimulating proliferation and inhibiting apoptosis of 
these cells (10). Furthermore, NOX4 is involved in TGF-1-induced human cardiac fibroblast 
differentiation into myofibroblasts (11). Therefore, we hypothetized that NOX1 and NOX4 
could be also expressed in parenchymal pulmonary fibroblasts and could mediate the effects 
of TGF-1. 
The aim of this study was to investigate NOX1 and NOX4 expression in pulmonary 
fibroblasts from control subjects and IPF patients and to analyse their respective role in 
mediating TGF-1-induced fibroblast differentiation into myofibroblast, a key phenomenon 
in IPF pathogenesis (12). The myofibroblast phenotype was analyzed by examining -SMA 
and procollagen I (1) expression. 
 
 
MS# THORAX/2009/113456 Re re revised 
 5 
MATERIAL AND METHODS 
See online supplement for further details. 
Lung fibrosis patients 
Fibroblasts were derived from lung tissue sampled from 8 IPF patients. Lung samples were 
obtained by open lung biopsy (n=4) or at the time of lung transplantation (n=4). IPF was 
diagnosed according to the ATS-ERS consensus criteria (17). Patients (6 males; 2 females) 
had a median age of 50 years [range, 44 to 69 yr]. 6 were ex-smokers, 1 never smoked and 1 
was an active smoker. At the time of lung sampling, 3 patients were treated with low dose 
oral corticosteroids, associated with azathioprin in one patient. 
Control patients 
Fibroblasts were derived from lung samples from 9 patients (6 males, 3 females) undergoing 
lung surgery for removal of a primary lung tumor. Normal lung was obtained from a 
noninvolved segment, remote from the solitary lesion. Median age was 54 years [28 to 68]. 
Two patients had never smoked, 4 were ex-smokers and 3 were active smokers. 
Culture of fibroblasts 
Human lung fibroblasts were cultured from lung explants until passage 5 as previously 
described (13). In some experiments, cells were incubated in the presence of TGF-1 (10 
ng/ml, R&D Systems, Lille, France) or vehicle. 
Cellular Toxicity 
Cellular toxicity and viability were assessed by trypan blue exclusion and lactate 
dehydrogenase (LDH) release in the medium, as described previously (14). 
Intracellular ROS production 
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Intracellular ROS production was quantified by measuring H2-DCFH-DA oxidation, as 
described previously (14) (15). Results are expressed in fluorescent arbitrary units. 
Real-time RT-PCR 
NOX1, 2, 3, 4 and 5, -SMA and procollagen I (1) mRNA expression were quantified by 
quantitative real-time RT-PCR by use of the PCR ABI 7700 apparatus (Applied Biosystems, 
Carlsbad, CA). Expression of mRNA was normalized to that of ubiquitin. In previous 
experiments, we verified that ubiquitin mRNA expression did not change during the different 
experimental conditions. 
Cell transfection with siRNA 
To suppress endogenous NOX4 expression, experiments involved a specific siRNA 
(Xeragon-Qiagen, Valencia, CA,) against NOX4 designed on the target region from the 
NOX4 gene (5'-AAACCGGCAGGAGUUUACCCAG-3'). Scrambled siRNA 
(nonhomologous to the human genome, 5'-AACCAGCAAGGUGUAUCGCCAC-3') was 
used as a control.  
Western blot analysis  
Western blot was performed as described previously (16) with use of the following 
antibodies: polyclonal anti-human NOX4 (1/1000, Novus Biologicals,
 
Inc., Littleton, CO), 
monoclonal anti -actin (1/3000, Sigma-Aldrich, Saint Quentin Fallavier, France), and 
monoclonal anti-human anti Smad 2 and 3 (1/500, R&D Systems, Lille, France). The 
expression of NOX4 was normalized in respect to the expression of -actin. The expression of 
non-phosphorylated Smad 2 (monoclonal antibody, 1/400, Cell Signalling, Saint Quentin 
Yvelines, France) was used to normalize the expression of phospho Smad 2/3.  
Cell migration assay 
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Cell motility was examined as previously described (17) using a modified Boyden chamber 
apparatus (Transwell Costar) in response to 24 h stimulation with rhPDGF-BB 10ng/ml  
(R&D systems) or media alone. Chemotactic index was determined as the ratio of cells 
moving in response to a chemoattractant relative to cells moving in response to media control. 
Immunohistochemical analysis  
Immunohistochemistry was performed as previously described (16). 4-6 m thick cryostat 
sections were fixed in acetone and reacted with the primary antibody rabbit polyclonal anti-
NOX4 (1/500 dilution, kindly provided by Pr Victor Thannickal, University of Alabama at 
Birmingham, Birmingham, Alabama). 
Statistical analysis 
See online supplement for further details. 
All the data are displayed as medians, interquartile range and minimum and maximum values. 
All of the analysis were performed by non-parametric tests. p<0.05 was considered as 
statistically significant. 
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RESULTS 
Expression of NOX mRNA and oxidants production in pulmonary fibroblasts 
Lung fibroblasts from control patients expressed NOX1, 2, 4 and 5 mRNA at similar degrees, 
whereas expression of NOX3 was not detected in these cells (fig 1A to D). When comparing 
IPF and C fibroblasts, NOX4 was the only NOX whose mRNA expression was increased in 
the former as compared to the latter condition (p=0.043). The increased NOX4 expression in 
IPF fibroblasts was confirmed at the protein level by western blot (p=0.025 C vs IPF, fig 1E). 
NOX4 mRNA and protein induction in IPF fibroblasts were accompanied by an increased 
intracellular ROS production in these cells as compared to control fibroblasts (p=0.028, fig 
1F). Immunohistochemistry performed on control and IPF lung samples demonstrated that 
lung fibroblasts expressed immunoreactive NOX-4 in situ in the fibrotic lung (fig 2). 
Bronchial and alveolar epithelial cells, and pulmonary endothelial cells also expressed 
immunoreactive NOX-4.   
Expression of markers of myofibroblast diferentiation 
The content of -SMA mRNA was increased in IPF fibroblasts as compared to controls 
(p=0.045, fig E1 in on line supplement) whereas procollagen I (1) mRNA content was 
similar in both groups (p=0.310, fig E1 in on line supplement). Analysis of fibroblasts from 
IPF patients showed a significant correlation between  -SMA or procollagen  I (1) mRNA 
and NOX4 mRNA expression (Spearman  = 0.994, p<0.0001 in both cases, fig E1 in on line 
supplement), suggesting a role of this NADPH oxidase homolog in myofibroblast 
differentiation.  
Effect of TGF-1 
Since NOX4 was overexpressed in IPF fibroblasts and correlated with markers of fibroblast 
differentiation into myofibroblast, and since TGF-1 is an essential inducer of myofibroblast 
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differentiation (5), we analyzed if TGF-1 modulated NOX4 expression by lung fibroblasts. 
Incubation of control fibroblasts with TGF-1 for 18h induced a 3-fold increase of NOX4 
mRNA content (fig 3A, p=0.014). In IPF fibroblasts, TGF-1 induced a 8-fold increase of 
NOX4 mRNA content (fig 3B, p=0.008). As expected, TGF-1 increased -SMA and 
procollagen  I (1) mRNA expression in control and IPF fibroblasts (fig 3A and B, p=0.009, 
p=0.008, p=0.034, and p=0.029 for  -SMA in control and IPF fibroblasts and for procollagen  
I (1) in control and IPF fibroblasts respectively). The increase in -SMA was also observed 
at the protein level (fig 3C). Incubation of control fibroblasts with TGF-1 induced a 
significant increase in ROS production, measured by oxidation of DCFH (fig 3C). This 
increase was more important in IPF than in control cells at 1, 3, and 24 h post-TGF-1 
(p=0.033, p=0.039 and p=0.028 at each time respectively, fig 3D).  
Role of NOX4 on TGF-1  induced myofibroblast differentiation  
We first examined if ROS, the product of NOX4 activity, were involved on TGF-1 induced 
myofibroblast differentiation. First, we examined the effect of the antioxidant N-
acetylcystein. Pretreatment of control and IPF fibroblasts for 1 h with N-acetylcysteine (1 
mM) totally prevented the increase of -SMA and procollagen  I (1) mRNA expression 
induced by TGF-1 (fig 3A, B and C). This result strongly suggested that the oxidant-
antioxidant imbalance is involved in the effect of TGF-1.  
In order to examine the involvement of NOX4 on TGF-1 effects, we first incubated the 
fibroblasts for 1 h with diphenylene iodonium (DPI, 10 M), an inhibitor of flavoprotein-
dependent oxidases including NOX (18). DPI prevented TGF-1 induced -SMA and 
procollagen  I (1) mRNA expression in both control and IPF fibroblasts (fig 3A, B and C).  
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Second, we examined the effects of cell transfection with a NOX4 siRNA.  NOX4 siRNA 
significantly reduced NOX4 mRNA levels at 24 h in both control and IPF fibroblasts whereas 
no such effect was observed with lipofectamine or scrambled siRNA (fig 4A and B).  
Transfection with NOX4 siRNA significantly inhibited the effect of TGF-1 on 
myofibroblats differentiation in both control and IPF cells (fig 4A and B). Indeed, expression 
of -SMA and procollagen  I (1) were reduced by 67% and 68% and by 64% and 54% in 
control and IPF fibroblasts respectively. These results demonstrate that NOX4 mediates the 
effect of TGF-1 on myofibroblast differentiation. 
It has to be noted that both N-acetylcysteine and DPI reversed NOX4 mRNA induction by 
TGF-1, showing probably an autocrine role of NOX4-derived ROS on NOX4 induction by 
TGF-1.  
None of the different pharmacological treatments and transfection procedures altered cell 
viability (data not shown). 
Role of NOX4 on TGF-1  induced SMAD 2 and 3 phosphorylation 
It has been shown that Smads mediate TGF-ß1 induction of -SMA in human lung fibroblasts 
(19) (20). Since phosphorylation of Smad2/3 can be modulated by ROS (11), we analyzed 
whether NOX4 was involved on Smad2/3 phosphorylation induced by TGF-1. The results of 
these experiments show that 1 h cell pretreatment with both N-acetylcysteine and DPI (1mM 
and 10 M respectively) prevented Smad2/3 phosphorylation induced by 18 h incubation with 
TGF-1 in control and IPF fibroblasts (fig 5A and B). Cell transfection with the NOX4 
siRNA gave similar results (fig 5A and B). These results demonstrate that NOX4-produced 
ROS are involved in Smad2/3 phosphorylation by TGF-1.  
Role of NOX4 on PDGF induced fibroblast migration  
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Finally, we analyzed if NOX4 was involved in fibroblasts migration induced by PDGF-BB, a 
strong migration stimulus. First, we examined if PDGF modulated NOX4 expression by lung 
fibroblasts. Incubation of control fibroblasts and IPF fibroblasts with PDGF for 24 h (10 
ng/ml) induced a 1.5 and 2.5-fold increase of NOX4 mRNA content respectively (fig E2 in 
online supplement, p=0.028 and p=0.002 respectively).  
Having demonstrated that NOX4 was upregulated by PDGF, we analyzed its role on cell 
migration by incubating cells with NAC or DPI. Both NAC and DPI suppressed PDGF-
induced fibroblasts migration in control and IPF fibroblasts, showing a role of NOX4 in this 
process (fig E2 in online supplement and data not shown).  
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DISCUSSION 
The main results of the present study are that (1) NOX4 mRNA expression was upregulated 
in pulmonary fibroblasts from patients with IPF and correlated with mRNA expression of -
SMA and procollagen I (1) mRNA; (2) TGF-ß1 upregulates NOX4, -SMA and procollagen 
I (1) mRNA and -SMA protein expression in control and IPF human pulmonary 
fibroblasts; (3) the change in -SMA and procollagen  I (1) expression in response to TGF-
ß1 requires NOX4-derived ROS; (4) NOX4 modulates -SMA and procollagen  I (1) 
expression by controlling activation of Smad 2/3, and (5) NOX4 modulates fibroblasts 
migration induced by PDGF-BB. These new findings support the notion that NOX4 is critical 
for modulation of pulmonary myofibroblast phenotype in IPF, probably by modulating the 
response to TGF-ß1 and PDGF. Similar results concerning the response to TGF-ß1 were very 
recently reported by Hecker and colleagues (21) in an article published after the present study 
was submitted for publication.  
Expression of NOX4 in control fibroblasts 
Expression of NOX4 protein was detected in lungs from both control subjects and patients 
with idiopathic pulmonary artery hypertension, the expression was predominantly in the 
medial layer of pulmonary arteries and was higher in patients than in controls (10). 
Accordingly, pulmonary artery adventitial fibroblasts in culture also expressed both NOX1 
and NOX4 (22). In agreement with these findings, in the present study we found that 
parenchymal pulmonary fibroblasts from control and IPF patients expressed both NOX1 and 
NOX4. This result is different from data reported in cardiac fibroblasts in which NOX1 
expression was barely detectable (11), stressing the cell specificity of NOX expression. To the 
best of our knowledge this is the first demonstration that non-vascular pulmonary fibroblasts 
express NOX. It is noteworthy that our experiments were performed on cells in the fifth 
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passage, since progressive down-regulation of NOX4 expression has been correlated with 
increasing passage number (23) . However, our immunohistochemical results demonstrate 
that fibroblasts do express immunoreactive NOX-4 in situ in the fibrotic lung. 
NOX4 up-regulation in IPF fibroblasts 
The mechanism(s) involved in NOX4 up-regulation in IPF fibroblasts are difficult to analyze 
since very few data concerning the regulation of NOX4 activity and expression are available. 
Recent data from recombinant NOX4 expression suggest that NOX4 enzymatic activity 
depends on the membrane-associated p22
phox
 subunit, whereas cytosolic subunits, 
phosphorylation, or interaction with Rac are apparently not required for its activation (24) 
(25). Concerning the regulation of gene expression, and the relevant transcription factors 
involved, very few data are available since promoter studies of NOX4 are lacking. Our data 
clearly show that TGF-1 increases NOX4 expression both in control and in IPF fibroblasts, 
in accordance with previous data in cardiac fibroblasts and airway smooth muscle (11) (26) 
(27). Interestingly, the increase was stronger in IPF fibroblasts than in controls. One can 
speculate that TGF-1 can be responsible of NOX4 up-regulation in IPF fibroblasts ex vivo 
via an autocrine loop since expression of TGF-1 has been shown to be increased in these 
cells (28) . Furthermore, high levels of TGF-1 produced by epithelial cells could contribute 
to up-regulation in fibroblasts in situ in the lung of IPF patients (29).  
NOX4 induction by TGF-1 was inhibited by N-acetylcysteine and DPI suggesting that 
NOX-produced ROS are implicated in NOX4 gene expression regulation. We obtained 
similar results in human alveolar bronchiolar and epithelial cell lines (14), but the molecular 
mechanisms involved are unknown. Clearly, more studies are needed to understand NOX4 
gene expression regulation in IPF fibroblasts.  
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Role of NOX4 on myofibroblasts differentiation in IPF 
Whatever the mechanism(s) involved in gene expression regulation, NOX4 was involved in 
myofibroblast differentiation in IPF. This conclusion is supported by 1) the correlation 
between basal NOX4 and -SMA and procollagen I (1) mRNA expression, and 2) the 
prevention of TGF-1 differentiating effects by the NOX4 siRNA. This last phenomenon was 
also observed in cardiac fibroblasts (11). It has to be noted that we can not ensure that NOX4-
produced ROS were involved in myofibroblats differentiation in the present study since we 
did not measure fibroblast ROS production in NOX4 siRNA treated cells. However, several 
experimental evidences strongly suggest that the effects we observed were mediated by ROS 
produced by NOX4. First, NOX4 was the only NOX homolog up regulated in IPF fibroblasts; 
second, ROS production was higher in these cells as compared to control cells, and third 
similar results in terms of -SMA and procollagen I (1) expression were obtained by 
incubating these cell with the antioxidant NAC and by transfecting them with a NOX4 
siRNA. Furthermore, a recent study with controlled recombinant expression of NOX4 
demonstrated a strong correlation between NOX4 mRNA level and ROS generation (30). 
Thus, in this experimental setting, the activity of NOX4 was demonstrated to depend directly 
on its gene expression levels. Moreover, we and others have previously shown that siRNA 
against NOX4 reduced basal ROS level in rat smooth muscle cells and in pulmonary 
epithelial cell lines significantly (14)  (31). Collectively, these data strongly support a role of 
NOX4-produced ROS on myofibroblast differentiation.  
Interestingly, immunohistochemistry showed a strong expression of NOX4 by hyperplastic 
alveolar epithelium in the fibrotic lung (fig 2). In the kidney, NOX4 has been involved in the 
regulation of epithelial-mesenchymal transition (32). Although not specifically studied, this 
phenomenon could also occur in the lung and implicate NOX4 in the fibrogenic process 
through multiple ways.    
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Role of NOX4 on TGF-1 induced myofibroblasts differentiation and PDGF-induced 
migration 
TGF-ß1 stimulates differentiation of fibroblasts into myofibroblasts using Smad 2/3 
signalling (20). After initial phosphorylation, Smad 2/3 activation in response to TGF-ß1 is 
prolonged (hours to days depending on the cell type). Interestingly, we showed that Smad 2/3 
phosphorylation was up-regulated by TGF-1 after 18 h of incubation. The antioxidant N-
acetylcysteine, the NOX inhibitor DPI, and the siRNA anti NOX4 lead to a marked inhibition 
of Smad2/3 phosphorylation, as demonstrated previously in human cardiac fibroblasts (11). 
These data imply that oxidants produced by NOX4 mediate -SMA and procollagen  I (1) 
upregulation in pulmonary fibroblasts in response to TGF-ß1 probably by stimulating 
phosphorylation and activation of Smads 2/3. In addition, NOX4 mediates PDGF-induced 
fibroblasts migration. 
In summary, we have shown NOX4 upregulation in pulmonary fibroblasts from IPF patients, 
and identified a novel role for NOX4 as essential mediator of Smad2/3 transcription factor 
activation in response to TGF-ß1 in pulmonary fibroblasts. Because of the critical role of 
TGF-ß1–induced myofibroblast activation in IPF, these data provide insight into novel 
mechanisms with potential therapeutic implications for IPF.  
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LEGENDS TO FIGURES 
Figure 1. A, B, C and D: NOX1, 2, 4 and 5 mRNA expression in lung fibroblasts from 
patients with idiopathic pulmonary fibrosis (IPF) compared to controls expressed as the ratio 
to ubiquitin mRNA levels. Data are presented as box-and-whiskers plot with median, 
interquartile range and minimum and maximum values. E: Typical western-blot and 
quantification of NOX4 protein expression (67 kD) in lung fibroblasts from patients with IPF 
and controls. NOX4 is expressed as the ratio to -actin expression. Data are presented as box-
and-whiskers plot with median, interquartile range and minimum and maximum values. F: 
reactive oxygen species production by IPF and control fibroblasts assessed by measurement 
of H2-DCFH-DA oxidation. The values, expressed as arbitrary fluorescence units, are 
presented as box-and-whiskers plot with median, interquartile range and minimum and 
maximum values. 
Figure 2. Detection of immunoreactive NOX-4 in the lung. Immunohistochemistry shows 
that bronchial and alveolar epithelial cells express NOX-4 in the normal lung. In IPF lung 
samples, hyperplastic alveolar cells and fibroblasts (arrows) are strongly labelled. The control 
antibody gave always a negative signal. 
Figure 3. A and B: Effect of TGF-1 in the presence or in the absence of N-acetylcysteine 
(NAC, 1 mM) or diphenylene iodonium (DPI, 10 μm) on NOX4,  smooth muscle actin (-
SMA) and procollagen I (1) mRNA expression in lung fibroblasts from controls and patients 
with idiopathic pulmonary fibrosis (IPF). Data are presented as box-and-whiskers plot with 
median, interquartile range and minimum and maximum values. C: Typical western blot and 
quantification of -SMA protein expression in lung fibroblasts after TGF-1 incubation in the 
presence or in the absence of NAC (1 mM) or DPI (10 μm). -SMA is expressed as the ratio 
to -actin expression. Data are presented as box-and-whiskers plot with median, interquartile 
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range and minimum and maximum values. D: TGF-1 stimulates ROS production in human 
lung fibroblasts. Control and IPF fibroblasts were stimulated with TGF- 1 for 1 to 24 h and 
ROS production was assessed by measurement of H2-DCFH-DA oxidation. The 4 figures 
show production by the 2 groups of cells after 1, 3 12 and 24 h post-TGF-1 respectively. 
Values are presented as box-and-whiskers plot with median, interquartile range and minimum 
and maximum values.  
Figure 4. A and B: Effect of cell transfection with a siRNA anti-NOX4 on NOX4, -SMA 
and procollagen I (1) mRNA expression induced by TGF-1 in lung fibroblasts from 
controls and patients with idiopathic pulmonary fibrosis (IPF). siScr : scrambled siRNA. 
NOX4, -SMA and procollagen I (1) mRNA levels are expressed as the ratio to ubiquitin 
mRNA levels. Values are presented as box-and-whiskers plot with median, interquartile range 
and minimum and maximum values.  
Figure 5. Typical western bolt showing the expression of phosphorylated (p-Smad 2/3) and 
non-phosphorylated (Smad 2/3) in human lung fibroblasts from controls and patients with 
idiopathic pulmonary fibrosis (IPF) after incubation with TGF-1 in the presence or in the 
absence of a scrambled siRNA (siScr), a siRNA anti-NOX4 (siNOX4), diphenylene iodonium 
(DPI, 10 μm) or N-acetylcysteine (NAC, 1 mM). Box-and-whiskers plot with median, 
interquartile range and minimum and maximum values show quantification of p-Smad 2/3 
expressed as the ratio of Smad 2/3 expression.  
 
 
 
 
 
 
 
